Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 6 to 7 amino acid residues in defined sequence
Reexamination Certificate
2005-02-01
2005-02-01
Weber, Jon P. (Department: 1653)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
6 to 7 amino acid residues in defined sequence
C514S015800, C514S016700, C514S017400, C514S018700, C530S327000, C530S328000
Reexamination Certificate
active
06849712
ABSTRACT:
Peptides capable of modulating β1 integrin subunit dependent cell adhesion which includes a C-terminal aromatic amino acid residue and an amino acid residue having a lipophilic alkyl side chain as the penultimate C-terminal residue are provided. These “LipAr” C-terminated peptides are typically capable of modulating the β1 integrin subunit dependent adhesion of cells, such as Ramos cells.
REFERENCES:
patent: 4505853 (1985-03-01), Goldstein et al.
patent: 5116368 (1992-05-01), McCarthy et al.
patent: 5359048 (1994-10-01), Ohba et al.
patent: 5382569 (1995-01-01), Cody et al.
patent: 5731409 (1998-03-01), Fields et al.
patent: 6013628 (2000-01-01), Skubitz et al.
patent: 347 890 (1989-12-01), None
patent: 0 347 890 (1989-12-01), None
patent: 576 898 (1994-01-01), None
patent: 0 576 898 (1994-01-01), None
patent: 008806039 (1988-08-01), None
patent: WO 8901942 (1989-03-01), None
patent: WO 9317047 (1993-09-01), None
patent: WO 9417097 (1994-08-01), None
patent: WO 0056350 (2000-09-01), None
Newsholme, Journal of Biological Chemistry 267(2), 810-18, 1992.*
Westerlink, Proc Natl Acad Sci 92, 4-21, 1995.*
Fields et al., “Chapter 3: Principles and Practice of Solid-Phase Peptide Synthesis,”Synthetic Peptides: A User's Guide, Grant, ed., W. H. Freeman & Co., New York, title page, publication page, table of contents, and pp. 77-183 (1992).
Furcht et al., “Editorial: Tumor Cell Invasion, Matrix Metalloproteinases, and the Dogma,”Laboratory Investigation, 70(6):781-783 (1994).
Guan et al., “Lymphoid Cells Recognize an Alternatively Spliced Segment of Fibronectin via the Integrin Receptor α4β1,”Cell, 60(1):53-61 (1990).
Guo et al., “Fibronectin Peptide (FN C/H V-Y) Assay and Stability in Human and Rat Plasma,” Abstract 4029, American Association of Pharmaceutical Scientists Annual Meeting, Nov. 14-18, New Orleans, LA (1999).
Hallenbeck et al., “Polymorphonuclear Leukocyte Accumulation in Brain Regions with Low Blood Flow During the Early Postischemic Period,”Stroke, 17(2):246-253 (1986).
Hines et al., “Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor β1 knockout mice,”Proceedings of the National Academy of Sciences, USA, 91(11):5187-5191 (1994).
Huebsch et al., “Endothelial Cell Interactions With Synthetic Peptides From the Carboxyl-Terminal Heparin-Binding Domains of Fibronectin,”Circulation Research, 77(1):43-53 (1995).
Humphries et al., “A Synthetic Peptide from Fibronectin Inhibits Experimental Metastasis of Murine Melanoma Cells,”Science, 223(4762):467-470 (1986).
Hynes, “Integrins: A Family of Cell Surface Receptors,”Cell, 48(4):549-554 (1987).
Iida et al., “Coordinate Role for Cell Surface Chondroitin Sulfate Proteoglycan and α4β1 Integrin in Mediating Melanoma Cell Adhesion to Fibronectin,”The Journal of Cell Biology, 118(2):431-444 (1992).
Jackson et al., “Potent α4β1 Peptide Antagonists as Potential Anti-Inflammatory Agents,”Journal of Medicinal Chemistry, 40(21):3359-3368 (1997).
Johnson, “8. The Cutaneous Circulation,”Laser-Doppler Blood Flowmetry, Shepherd et al., eds., Kluver Academic Publishers, Norwell, MA, Title page, publication page, and pp. 121-139 (1990).
Kochanek et al., “Polymorphonuclear Leukocytes and Monocytes/Macrophages in the Pathogenesis of Cerebral Ischemia and Stroke,”Stroke, 23(9):1367-1379 (1992).
Lasky, “Selectins: Interpreters of Cell-Specific Carbohydrate Information During Inflammation,”Science, 258(5084):964-969 (1992).
Lauer et al., “Inhibition of Melanoma Cell Binding to Type IV Collagen by Analogs of Cell Adhesion Regulator,”Journal of Medicinal Chemistry, 40(19):3077-3084 (1997).
Levrey et al., “Induction of Fibroblast Apoptosis by Soluble Fibronectin Peptides,” Abstract 1050, 37thAnnual Meeting of the American Society for Cell Biology, Dec. 13-17, 1997, Washington, D.C.,Molecular Biology of the Cell, 8:181A (Nov., 1997).
Lobb et al., “Small molecule antagonists of α4 integrins: novel drugs for asthma,”Exp. Opin. Invest. Drugs, 8(7):935-945 (Jul., 1999).
Madden et al., “A peptide derived from neutrophil inhibitory factor (NIF) blocks neutrophil adherence to endothelial cells,”Inflammation Research, 46(6):216-223 (1997).
Matsuo et al., “Role of Neutrophils in Radical Production During Ischemia and Reperfusion of the Rat Brain: Effect of Neutrophil Depletion on Extracellular Ascorbyl Radical Formation,”Journal of Cerebral Blood Flow and Metabolism, 15(6):941-947 (1995).
McCarthy et al., “Laminin and Fibronectin Promote the Haptotactic Migration of B16 Mouse Melanoma Cells In Vitro,”The Journal of Cell Biology, 98(4):1474-1480 (1984).
McCarthy et al., The role of cell adhesion proteins—laminin and fibronectin—in the movement of malignant and metastatic cells,Cancer and Metastatis Reviews, 4(2):125-152 (1985).
Norgard-Sumnicht et al., “Calcium-Dependent Heparin-Like Ligands for L-Selectin in Nonlymphoid Endothelial Cells,”Science, 261(5120):480-483.
Parker et al., “New Hydrophilicity Scale Derived from High-Performance Liquid Chromatography Peptide Retention Data: Correlation of Predicted Surface Residues with Antigenicity and X-ray-Derived Accessible Sites,”Biochemistry, 25(19):5425-5432 (1986).
Prosper et al., “Mobilization and Homing of Peripheral Blood Progenitors Is Related to Reversible Downregulation of α4β1 Integrin Expression and Function,”The Journal of Clinical Investigation, 101(11):2456-2467 (1998).
Radzicka et al., “Comparing the Polarities of the Amino Acids: Side-Chain Distribution Coefficients between the Vapor Phase, Cyclohexane, 1-Octanol, and Neutral Aqueous Solution,”Biochemistry, 27(5):1664-1670 (1988).
Ruoslahti, “Integrins,”The Journal of Clinical Investigation, 87(1):1-5 (1991).
Springer, “Adhesion receptors of the immune system,”Nature, 346(6283):425-434 (1990).
Springer, “Folding of the N-terminal, ligand-binding region of integrin α-subunits into a β-propeller domain,”Proceedings of the National Academy of Sciences USA, 94(1):65-72 (1997).
Wahl et al., “Synthetic Fibronectin Peptides Suppress Arthirits in Rats by Interrupting Leukocyte Adhesion and Recruitment,”The Journal of Clinical Investigation, 94(2):655-662 (1994).
Weiss, “Tissue Destruction by Neutrophils,”The New England Journal of Medicine, 320(6):365-376 (1989).
Woods et al., “A Synthetic Peptide from the COOH-Terminal Heparin-binding Domain of Fibronectin Promotes Focal Adhesion Formation,”Molecular Biology of the Cell, 4(6):605-613 (1993).
Cue et al., “A nonpeptide integrin antagonist can inhibit epithelial cell ingestion ofStreptococcus pyogenesby blocking formation of integrin alpha 5beta 1-fibronectin-M1 protein complexes,”Proceedings of the National Academy of Sciences, USA, 97(6):2858-63 (2000).
Duan et al., “Enhancement of nigral graft survival in rat brain with the systemic administration of synthetic fibronectin peptide V,”Neuroscience, 100(3):521-30 (2000).
Humphries et al., “An Anthropomorphic Integrin,”Science, 294(5541):316-7 (2001).
Lasky, “How Integrins Are Activated,”Nature, 390(6655):15, 17 (1997).
Lenter et al., “A Monoclonal Antibody Against an Activation Epitope on Mouse Integrin Chain β1Blocks Adhesion of Lymphocytes to the Endothelial Integrin α6β1,”Proceedings of the National Academy of Sciences, USA, 90(19):9051-9055 (1993).
McCarthy et al., “Human monocyte binding to fibronectin enhances IFN-gamma-induced early signaling events,”The Journal of Immunology, 159(5):2424-30 (1997).
Xiong et al., “Crystal Structure of the Extracellular Segment of Integrin
Frey Angela Brienzo
Furcht Leo T.
McCarthy James B.
Lukton David
Mueting Raasch & Gebhardt, P.A.
Regents of the University of Minnesota
Weber Jon P.
LandOfFree
Peptides with β1 integrin subunit dependent cell... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides with β1 integrin subunit dependent cell..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides with β1 integrin subunit dependent cell... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3482690